Current Issue

VOLUME 3, NOVEMBER ISSUE 11 — 2026

8 articles · Open access · Browse the latest published research in WJAPS.

PHYTOCHEMICAL STUDY AND LARVICIDAL ACTIVITY OF THREE EXTRACTS FROM CASSIA SIEBERIANA BARK

Authors: Mamadou Kébé, *El Hadji Gorgui DIOUF, Mamadou Latyr Ndour, Adama Faye, Abdou Sarr, Talibouya Ndior, Ndeye Bineta Camara, Mamadou Ngom, Baboucar Sarr, Aboubacry Sène

Malaria, caused by protozoa of the genus Plasmodium, is endemic in sub-Saharan Africa, and vector control remains the main intervention for reducing its transmission. Synthetic insecticides, although very effective against exposed mosquitoes, cause environmental problems, which motivates the search for plant-based alternatives. In this study, three extracts (cyclohexane, chloroform and methanol) were prepared by maceration from the bark of Cassia sieberiana, screened phytochemically and tested at four doses (50 to 6.25 mg/mL) on third-stage larvae of Anopheles gambiae. The extraction yield was highest with methanol (17.42%), against about 1% with cyclohexane and chloroform. Phytochemical screening showed that the methanolic extract was rich in polyphenols, flavonoids and tannins, whereas alkaloids were absent from all extracts. Mean larval mortality was just under 70% and increased with both dose and exposure time. The methanolic extract was the most active, with 85% mortality after 48 h of exposure, an activity that may be related to its high polyphenol content. Analysis of variance showed significant effects of extract, dose and exposure time (P < 0.05). These results suggest that C. sieberiana bark is a potential source of bioinsecticides against malaria vectors.
Research Article
PHYTOCHEMICAL STUDY AND LARVICIDAL ACTIVITY OF THREE EXTRACTS FROM CASSIA SIEBERIANA BARK

LIFESTYLE MODIFICATION AND PHARMACOTHERAPY IN RECURRENT URINARY TRACT INFECTION

Authors: *Trupti Rajkumar Waghnare, Akshay Anand, Manthan Mirkale, Dr. P. N. Kelgoankar

Recurrent urinary tract infection (rUTI) is a common clinical problem, particularly among women, and is associated with repeated antibiotic exposure, reduced quality of life and increasing antimicrobial resistance. Recurrent cystitis is generally defined as at least two episodes within 6 months or three episodes within 12 months. Management involves confirmation of infection, identification of predisposing factors and prevention of further episodes. Lifestyle interventions such as adequate fluid intake, avoiding delayed urination and appropriate personal hygiene may reduce recurrence in selected patients. Pharmacological prevention includes non-antibiotic approaches such as vaginal estrogen, methenamine hippurate, cranberry products and selected probiotics, as well as antibiotic prophylaxis when appropriate. Current guidelines increasingly emphasize antimicrobial stewardship and the use of non-antibiotic strategies before long-term antibiotics. � Uroweb +1
Review Article
LIFESTYLE MODIFICATION AND PHARMACOTHERAPY IN RECURRENT URINARY TRACT INFECTION

REVIEW ARTICLE: SADVRITTA AND ITS CLINICAL APPLICATION IN DAY-TO-DAY PRACTICE

Authors: *Dr. Aishwarya Hubballi, Dr. Raosaheb A. Deshmukh, Dr. Renuka Tenahalli, Dr. Jyothi P. Baragi, Dr. Sachin Bagali

Background: Modern lifestyle disorders are rapidly increasing due to stress, improper dietary habits, and erratic daily schedules. Ayurveda emphasizes preventive health through Swastha Chatuska, where Sadvritta (code of righteous conduct) plays a pivotal role. Objective: This review explores the conceptual framework of Sadvritta and evaluates its practical, day-to-day application in maintaining mental, social, and physical well-being. Materials and Methods: Classical Ayurvedic treatises including Charaka Samhita, Sushruta Samhita, and Ashtanga Hrudaya were reviewed along with contemporary literature on behavioral psychology and psychosomatic medicine. Discussion: Sadvritta bridges the gap between mental hygiene and physical health by suppressing Pragyaparadha (intellectual blasphemy), the root cause of many psychosomatic illnesses. Adherence to ethical conduct, emotional regulation, and social harmony directly modulates the neuroendocrine axis, reducing stress-induced pathology. Conclusion: Sadvritta is not merely a moral code but a validated preventive healthcare tool. Integrating these behavioral guidelines into daily routines offers a sustainable, cost-effective shield against contemporary lifestyle disorders.
Review Article
REVIEW ARTICLE: SADVRITTA AND ITS CLINICAL APPLICATION IN DAY-TO-DAY PRACTICE

DRAVYAGUNA VIJNANA AND PHYTOCHEMISTRY: A COMPREHENSIVE REVIEW ON PLANT SECONDARY METABOLITES AND THEIR THERAPEUTIC PHARMACODYNAMICS

Authors: Dr. Kishor Kumar Kumatad*, Dr. Vidyalaxmi Pujari, Dr. Shashidhar Naik

Plants produce a rich variety of natural compounds known as secondary metabolites. While these chemicals are not required for a plant's basic daily growth, they play vital roles in helping the plant survive, defend itself against pests and diseases, and adapt to harsh environmental conditions. In both modern medicine and traditional Ayurvedic science (Dravyaguna Vijnana), these active plant compounds form the biological foundation for how herbal remedies work and how new medicinal drugs are discovered. This comprehensive review bridges ancient wisdom and modern science by exploring the chemical structures, natural sources, healing mechanisms, and Ayurvedic equivalents of six major groups of plant compounds: Phenolics, Alkaloids, Saponins, Terpenes, Lipids, and Carbohydrates.
Review Article
DRAVYAGUNA VIJNANA AND PHYTOCHEMISTRY: A COMPREHENSIVE REVIEW ON PLANT SECONDARY METABOLITES AND THEIR THERAPEUTIC PHARMACODYNAMICS

BEYOND TUMOUR VISIBILITY: A BIOMARKER-DRIVEN PHARMACOLOGICAL REVIEW OF CUTANEOUS, ORAL CAVITY AND BREAST MALIGNANCIES

Authors: Devanssh Mehta*

Cancer pharmacotherapy is increasingly guided by molecular characteristics that distinguish biologically heterogeneous tumours and predict their susceptibility to specific interventions. Externally accessible malignancies, including cutaneous melanoma, keratinocyte carcinomas, oral squamous cell carcinoma and breast cancer, offer opportunities for clinical inspection, tissue sampling and longitudinal assessment; however, accessibility does not establish tumour biology or predict therapeutic response. This narrative review examines the molecular pathogenesis, pharmacological vulnerabilities and clinical applications of biomarkers across these malignancies. Evidence was synthesised conceptually from established clinical guidelines, peer-reviewed studies and authoritative oncology resources, with emphasis on clinically actionable biomarkers and recognised limitations of emerging assays. BRAF alterations inform targeted treatment selection in melanoma, while Hedgehog pathway dysregulation provides a therapeutic rationale for selected advanced basal cell carcinomas. In breast cancer, oestrogen and progesterone receptors, HER2, PIK3CA and BRCA1/2 alterations inform distinct endocrine, targeted and DNA repair-directed strategies. PD-L1 assessment contributes to treatment selection in defined head and neck and breast cancer settings. The review also evaluates pharmacokinetic and pharmacodynamic principles, immune-mediated toxicity, acquired resistance, intratumour heterogeneity and circulating tumour DNA. A central finding is that biomarker utility depends on assay validity, tumour context and demonstrated clinical benefit rather than the mere detection of a molecular alteration. Integrating histopathology, validated molecular diagnostics, pharmacological assessment and patient-centred decision-making offers a rational foundation for precision oncology. Future advances require prospective validation, equitable diagnostic access and evidence that biomarker-guided interventions improve survival, treatment tolerability or quality of life.
Review Article
BEYOND TUMOUR VISIBILITY: A BIOMARKER-DRIVEN PHARMACOLOGICAL REVIEW OF CUTANEOUS, ORAL CAVITY AND BREAST MALIGNANCIES

POSTOPERATIVE INFECTION RATES IN MINOR ORAL SURGERY ARE CLOSELY LINKED TO ANTIBIOTIC PRESCRIBING PRACTICES, WITH EVIDENCE SHOWING THAT BOTH UNDERUSE AND OVERUSE CAN NEGATIVELY IMPACT PATIENT OUTCOMES

Authors: Dr. Sultan Mohammed Riyaan Zaid, *Dr. Mohammed Abdul Naveed, Dr. K. N. Phalguni, Dr. Hemanjani Koduru, Dr. Ghazala Hussain, Dr. Misbah Rizwana, Dr. Konda Jutur Dakshitha

Background: Minor oral surgical procedures, including third molar extractions and alveoloplasty, are associated with postoperative complications, most notably infection and alveolar osteitis. Clinicians frequently prescribe antibiotics prophylactically, yet their association with infection rates remains controversial. Objective: This review evaluates postoperative infection rates in minor oral surgery and their correlation with antibiotic prescribing patterns, drawing on evidence from randomised controlled trials, systematic reviews and clinical guidelines. Methods: A narrative literature review was conducted of PubMed-indexed studies, including randomised clinical trials, meta-analyses and consensus guidelines, selected to provide a balanced overview of infection incidence, antibiotic efficacy and prescribing trends. Fifty publications were screened; after removal of duplicates and records that could not be verified, 45 unique sources informed the review and 32 are cited here. Results: Reported infection rates in minor oral surgery range from 0.5–5% in routine extractions to 10–15% in impacted third molar surgery. Evidence demonstrates that routine prophylactic antibiotics in healthy patients do not significantly reduce infection rates. Prolonged courses beyond 24 hours offer no added benefit. Selective prophylaxis is effective in high-risk cases, such as immunocompromised patients or procedures exceeding 30–60 minutes. Overprescription contributes to antimicrobial resistance and unnecessary adverse drug reactions. Conclusion: Postoperative infection rates in minor oral surgery are relatively low, and routine antibiotic prophylaxis is not justified in healthy individuals. Judicious, evidence-based prescribing—limited to high-risk scenarios—reduces infection risk while mitigating antimicrobial resistance. Regular audits, adherence to stewardship guidelines and patient education are essential to optimise outcomes.
Review Article
POSTOPERATIVE INFECTION RATES IN MINOR ORAL SURGERY ARE CLOSELY LINKED TO ANTIBIOTIC PRESCRIBING PRACTICES, WITH EVIDENCE SHOWING THAT BOTH UNDERUSE AND OVERUSE CAN NEGATIVELY IMPACT PATIENT OUTCOMES

IN VITRO EVALUATION OF HYPOLIPIDEMIC AND ANTIOXIDANT ACTIVITIES OF METHANOLIC EXTRACT OF SCHIZOPHYLLUM COMMUNE

Authors: Ahalyadevi K. H.*, Naveen Kumar B. M., Gowrisha M. S., Shivani

The present study was undertaken to evaluate the in-vitro hypolipidemic and antioxidant activities of Schizophyllum commune. The mushroom was extracted using methanol and the obtained extract was subjected to preliminary phytochemical screening to identify the major bioactive constituents. The antioxidant activity of the extract was evaluated by DPPH radical scavenging assay, which determines the free radical scavenging ability of the extract. The hypolipidemic potential was assessed by pancreatic lipase enzyme inhibition assay using p-nitrophenyl butyrate as the substrate. The methanolic extract exhibited concentration-dependent antioxidant activity, as evidenced by an increase in DPPH radical scavenging activity with increasing extract concentration. The extract also demonstrated concentration-dependent inhibition of pancreatic lipase enzyme, indicating its potential to interfere with dietary lipid digestion. The observed activities may be attributed to the presence of bioactive constituents such as phenolic compounds, flavonoids, polysaccharides and other secondary metabolites. Overall, the findings suggest that Schizophyllum commune may serve as a promising natural source of antioxidant and lipid-metabolism-related bioactive compounds. Further studies involving isolation of active constituents and in-vivo evaluation are required to establish its pharmacological potential.
Research Article
IN VITRO EVALUATION OF HYPOLIPIDEMIC AND ANTIOXIDANT ACTIVITIES OF METHANOLIC EXTRACT OF SCHIZOPHYLLUM COMMUNE

PHARMACEUTICAL STUDY ON DEVELOPMENT OF NOOLA MALAHARA - TOPICAL DOSAGE FORM

Authors: Dr. Praveen Chougala*, Dr. Prasadshakti Gannur, Dr. Kashinath S. H., Dr. Aneesur Rehman Madni

Background: Noola Taila, described by Acharya Vangasena in the context of Agantuka Vrana Rogadhikara, is a medicated oil of the Sneha Kalpana group used for wounds and is attributed with Vrana Ropana (wound healing) activity. Its application in the form of Noola Malahara is intended for the management of Parikartika. Objective: Noola Malahara was formulated as a semisolid dosage form using Noola Taila as the base material. Methods: A Kwatha was prepared from coarse powder of Bala moola (2 kg) and Apamarga moola (2 kg) with 8 parts of water, reduced to one-fourth. This was boiled with Tila taila (2 litres) on mild fire with continuous stirring until Sneha siddhi lakshana appeared. Noola Malahara was then prepared as per the Malahara Kalpana of Rasatarangini by adding Sikta (390 g) to hot Noola Taila (1950 ml) in a 1:5 ratio. Results: For the preparation of Noola Malahara, 390 g of Sikta was added to the hot Noola Taila and thoroughly mixed. The mixture was allowed to stand for approximately 30 minutes to facilitate proper mixing and setting. A total of 32 tubes of Noola Malahara were prepared, with each tube containing approximately 45 g of Malahara. Conclusion: Classical Ayurvedic methods can be applied to prepare Noola Taila and its Malahara form. Further clinical evaluation is recommended to establish its efficacy in wound healing and anorectal disorders such as Parikartika.
Research Article
PHARMACEUTICAL STUDY ON DEVELOPMENT OF NOOLA MALAHARA - TOPICAL DOSAGE FORM

No matching articles

Try another keyword.